1. Home
  2. IVVD vs NRC Comparison

IVVD vs NRC Comparison

Compare IVVD & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.63

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$13.39

Market Cap

428.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVVD
NRC
Founded
2020
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.1M
428.2M
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
IVVD
NRC
Price
$1.63
$13.39
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.1M
128.2K
Earning Date
04-13-2026
05-05-2026
Dividend Yield
N/A
4.62%
EPS Growth
20.99
N/A
EPS
N/A
0.43
Revenue
$25,384,000.00
$119,686,000.00
Revenue This Year
$107.86
N/A
Revenue Next Year
$146.53
N/A
P/E Ratio
N/A
$32.58
Revenue Growth
N/A
1.81
52 Week Low
$0.46
$9.76
52 Week High
$3.07
$22.79

Technical Indicators

Market Signals
Indicator
IVVD
NRC
Relative Strength Index (RSI) 41.64 39.89
Support Level $1.41 $13.19
Resistance Level $2.01 $14.20
Average True Range (ATR) 0.10 0.93
MACD 0.03 0.21
Stochastic Oscillator 46.30 50.78

Price Performance

Historical Comparison
IVVD
NRC

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

Share on Social Networks: